{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:22:38Z","timestamp":1790061758199,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"crossref","award":["DP 130100389"],"award-info":[{"award-number":["DP 130100389"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS082094"],"award-info":[{"award-number":["R01NS082094"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011075","name":"David Geffen School of Medicine, University of California, Los Angeles","doi-asserted-by":"publisher","award":["Donations"],"award-info":[{"award-number":["Donations"]}],"id":[{"id":"10.13039\/100011075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12311-019-01012-w","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T13:26:46Z","timestamp":1550496406000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)"],"prefix":"10.1007","volume":"18","author":[{"given":"Olivier J.","family":"Becherel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent L.","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott I.","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemamali","family":"Samaratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Greaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Homer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1172-1-47","volume":"1","author":"F Palau","year":"2006","unstructured":"Palau F, Espinos C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47.","journal-title":"Orphanet J Rare Dis"},{"key":"1012_CR2","first-page":"1320","volume":"67","author":"AH Nemeth","year":"2000","unstructured":"Nemeth AH, Bochukova E, Dunne E, et al. Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34. Am J Hum Genet. 2000;67:1320\u20136.","journal-title":"Am J Hum Genet"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng1303","volume":"36","author":"MC Moreira","year":"2004","unstructured":"Moreira MC, Klur S, Watanabe M, N\u00e9meth AH, Ber IL, Moniz JC, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet. 2004;36:225\u20137.","journal-title":"Nat Genet"},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/MCB.01195-12","volume":"33","author":"O Yuce","year":"2013","unstructured":"Yuce O, West SC. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol Cell Biol. 2013;33:406\u201317.","journal-title":"Mol Cell Biol"},{"key":"1012_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1083\/jcb.200701042","volume":"177","author":"A Suraweera","year":"2007","unstructured":"Suraweera A, Becherel OJ, Chen P, Rundle N, Woods R, Nakamura J, et al. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J Cell Biol. 2007;177:969\u201379.","journal-title":"J Cell Biol"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1093\/hmg\/ddp278","volume":"18","author":"A Suraweera","year":"2009","unstructured":"Suraweera A, Lim Y, Woods R, Birrell GW, Nasim T, Becherel OJ, et al. Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum Mol Genet. 2009;18:3384\u201396.","journal-title":"Hum Mol Genet"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.jocn.2013.11.048","volume":"21","author":"RH Roda","year":"2014","unstructured":"Roda RH, Rinaldi C, Singh R, Schindler AB, Blackstone C. Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage. J Clin Neurosci. 2014;21:1627\u201331.","journal-title":"J Clin Neurosci"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1093\/hmg\/ddv296","volume":"24","author":"OJ Becherel","year":"2015","unstructured":"Becherel OJ, Sun J, Yeo AJ, Nayler S, Fogel BL, Gao F, et al. A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. Hum Mol Genet. 2015;24:5759\u201374.","journal-title":"Hum Mol Genet"},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1093\/hmg\/ddu190","volume":"23","author":"BL Fogel","year":"2014","unstructured":"Fogel BL, Cho E, Wahnich A, Gao F, Becherel OJ, Wang X, et al. Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2. Hum Mol Genet. 2014;23:4758\u201369.","journal-title":"Hum Mol Genet"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ni.3132","volume":"16","author":"MS Miller","year":"2015","unstructured":"Miller MS, Rialdi A, Ho JS, et al. Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis. Nat Immunol. 2015;16:485\u201394.","journal-title":"Nat Immunol"},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.dnarep.2010.10.012","volume":"10","author":"A De Amicis","year":"2011","unstructured":"De Amicis A, Piane M, Ferrari F, Fanciulli M, Delia D, Chessa L. Role of senataxin in DNA damage and telomeric stability. DNA Repair (Amst). 2011;10:199\u2013209.","journal-title":"DNA Repair (Amst)"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2011.04.026","volume":"42","author":"K Skourti-Stathaki","year":"2011","unstructured":"Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA\/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell. 2011;42:794\u2013805.","journal-title":"Mol Cell"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1101\/gad.224923.113","volume":"27","author":"P Richard","year":"2013","unstructured":"Richard P, Feng S, Manley JL. A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes Dev. 2013;27:2227\u201332.","journal-title":"Genes Dev"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/brain\/awp211","volume":"132","author":"M Anheim","year":"2009","unstructured":"Anheim M, Monga B, Fleury M, Charles P, Barbot C, Salih M, et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients. Brain. 2009;132:2688\u201398.","journal-title":"Brain"},{"key":"1012_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1212\/01.wnl.0000208402.10512.4a","volume":"66","author":"C Criscuolo","year":"2006","unstructured":"Criscuolo C, Chessa L, Di Giandomenico S, et al. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology. 2006;66:1207\u201310.","journal-title":"Neurology"},{"key":"1012_CR16","doi-asserted-by":"publisher","first-page":"e1003435","DOI":"10.1371\/journal.pgen.1003435","volume":"9","author":"OJ Becherel","year":"2013","unstructured":"Becherel OJ, Yeo AJ, Stellati A, Heng EYH, Luff J, Suraweera AM, et al. Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet. 2013;9:e1003435.","journal-title":"PLoS Genet"},{"key":"1012_CR17","doi-asserted-by":"publisher","first-page":"15025","DOI":"10.1038\/celldisc.2015.25","volume":"1","author":"AJ Yeo","year":"2015","unstructured":"Yeo AJ, Becherel OJ, Luff JE, Graham ME, Richard D, Lavin MF. Senataxin controls meiotic silencing through ATR activation and chromatin remodeling. Cell Discov. 2015;1:15025.","journal-title":"Cell Discov"},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/B978-0-444-64189-2.00023-8","volume":"155","author":"M Manto","year":"2018","unstructured":"Manto M, Hampe CS. Endocrine disorders and the cerebellum: from neurodevelopmental injury to late-onset ataxia. Handb Clin Neurol. 2018;155:353\u201368.","journal-title":"Handb Clin Neurol"},{"key":"1012_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fgene.2018.00529","volume":"9","author":"DA Fink","year":"2018","unstructured":"Fink DA, Nelson LM, Pyeritz R, Johnson J, Sherman SL, Cohen Y, et al. Fragile X associated primary ovarian insufficiency (FXPOI): case report and literature review. Front Genet. 2018;9:529.","journal-title":"Front Genet"},{"key":"1012_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/brain\/awh080","volume":"127","author":"I Le Ber","year":"2004","unstructured":"Le Ber I, Bouslam N, Rivaud-Pechoux S, et al. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain. 2004;127:759\u201367.","journal-title":"Brain"},{"key":"1012_CR21","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/ajmg.a.31816","volume":"143A","author":"DR Lynch","year":"2007","unstructured":"Lynch DR, Braastad CD, Nagan N. Ovarian failure in ataxia with oculomotor apraxia type 2. Am J Med Genet A. 2007;143A:1775\u20137.","journal-title":"Am J Med Genet A"},{"key":"1012_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/mus.21328","volume":"40","author":"J Gazulla","year":"2009","unstructured":"Gazulla J, Benavente I, Lopez-Fraile IP, Modrego P, Koenig M. Sensorimotor neuronopathy in ataxia with oculomotor apraxia type 2. Muscle Nerve. 2009;40:481\u20135.","journal-title":"Muscle Nerve"},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12311-009-0130-8","volume":"8","author":"BL Fogel","year":"2009","unstructured":"Fogel BL, Lee JY, Perlman S. Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2. Cerebellum. 2009;8:448\u201353.","journal-title":"Cerebellum"},{"key":"1012_CR24","doi-asserted-by":"publisher","first-page":"e90219","DOI":"10.1371\/journal.pone.0090219","volume":"9","author":"AJ Yeo","year":"2014","unstructured":"Yeo AJ, Becherel OJ, Luff JE, Cullen JK, Wongsurawat T, Jenjaroenpoon P, et al. R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS One. 2014;9:e90219.","journal-title":"PLoS One"},{"key":"1012_CR25","doi-asserted-by":"publisher","first-page":"9585","DOI":"10.1073\/pnas.160274797","volume":"97","author":"DH Castrillon","year":"2000","unstructured":"Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP. The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci U S A. 2000;97:9585\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1012_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1247\/csf.26.131","volume":"26","author":"T Noce","year":"2001","unstructured":"Noce T, Okamoto-Ito S, Tsunekawa N. Vasa homolog genes in mammalian germ cell development. Cell Struct Funct. 2001;26:131\u20136.","journal-title":"Cell Struct Funct"},{"key":"1012_CR27","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem. 1998;273:5858\u201368.","journal-title":"J Biol Chem"},{"key":"1012_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jmr.2284","volume":"26","author":"DD Phillips","year":"2013","unstructured":"Phillips DD, Garboczi DN, Singh K, Hu Z, Leppla SH, Leysath CE. The sub-nanomolar binding of DNA-RNA hybrids by the single-chain Fv fragment of antibody S9.6. J Mol Recognit. 2013;26:376\u201381.","journal-title":"J Mol Recognit"},{"key":"1012_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-1759(86)90040-2","volume":"89","author":"SJ Boguslawski","year":"1986","unstructured":"Boguslawski SJ, Smith DE, Michalak MA, Mickelson KE, Yehle CO, Patterson WL, et al. Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J Immunol Methods. 1986;89:123\u201330.","journal-title":"J Immunol Methods"},{"key":"1012_CR30","volume-title":"Ataxia-telangiectasia","author":"R Gatti","year":"2016","unstructured":"Gatti R, Perlman S. Ataxia-telangiectasia. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. . Seattle: GeneReviews((R)); 2016."},{"key":"1012_CR31","volume-title":"Nijmegen breakage syndrome","author":"R Varon","year":"2017","unstructured":"Varon R, Demuth I, Chrzanowska KH. Nijmegen breakage syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. . Seattle: GeneReviews((R)); 2017."},{"key":"1012_CR32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/hmg\/ddi005","volume":"14","author":"YM Kuo","year":"2005","unstructured":"Kuo YM, Duncan JL, Westaway SK, Yang H, Nune G, Xu EY, et al. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet. 2005;14:49\u201357.","journal-title":"Hum Mol Genet"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12311-019-01012-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-019-01012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-019-01012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:51:47Z","timestamp":1589734307000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12311-019-01012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s12311-019-01012-w","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"18 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal work and experiments have been approved by The University of Queensland Animal Ethics Committee (HMRC\/UQCCR\/155\/15\/ARC). Written informed consent was obtained to collect biological samples from patients\u00a0for further analysis. All study methods were approved by the Institutional Review Board of the University of California, Los Angeles (UCLA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}